REGN · Regeneron Pharmaceuticals, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-02 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 200 shares of Company stock on July 2, 2026 at prices ranging from $650.10 to $650.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 2, 2026 at each separate price. |
Common Stock
|
200 |
| 2026-05-01 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 2 shares of Company stock on May 1, 2026 at prices ranging from $714.12 to $714.14. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2026 at each separate price. |
Common Stock
|
2 |
| 2026-05-01 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 24 shares of Company stock on May 1, 2026 at prices ranging from $703.01 to $703.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2026 at each separate price. |
Common Stock
|
24 |
| 2026-05-01 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 4 shares of Company stock on May 1, 2026 at prices ranging from $707.12 to $707.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2026 at each separate price. |
Common Stock
|
4 |
| 2026-05-01 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 15 shares of Company stock on May 1, 2026 at prices ranging from $702.02 to $702.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2026 at each separate price. |
Common Stock
|
15 |
| 2026-05-01 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 2 shares of Company stock on May 1, 2026 at prices ranging from $710.86 to $710.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2026 at each separate price. |
Common Stock
|
2 |
| 2026-05-01 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. |
Common Stock
|
1 |
| 2026-05-01 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 14 shares of Company stock on May 1, 2026 at prices ranging from $705.02 to $705.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2026 at each separate price. |
Common Stock
|
14 |
| 2026-05-01 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 6 shares of Company stock on May 1, 2026 at prices ranging from $709.05 to $709.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2026 at each separate price. |
Common Stock
|
6 |
| 2026-05-01 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 7 shares of Company stock on May 1, 2026 at prices ranging from $706.05 to $706.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2026 at each separate price. |
Common Stock
|
7 |
| 2026-05-01 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 15 shares of Company stock on May 1, 2026 at prices ranging from $704.01 to $704.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2026 at each separate price. |
Common Stock
|
15 |
| 2026-05-01 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 5 shares of Company stock on May 1, 2026 at prices ranging from $701.36 to $701.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2026 at each separate price. |
Common Stock
|
5 |
| 2026-05-01 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 5 shares of Company stock on May 1, 2026 at prices ranging from $711.17 to $711.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2026 at each separate price. |
Common Stock
|
5 |
| 2026-04-01 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 13 shares of Company stock on April 1, 2026 at prices ranging from $776.11 to $776.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. |
Common Stock
|
13 |
| 2026-04-01 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. |
Common Stock
|
1 |
| 2026-04-01 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 9 shares of Company stock on April 1, 2026 at prices ranging from $777.03 to $777.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. |
Common Stock
|
9 |
| 2026-04-01 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 8 shares of Company stock on April 1, 2026 at prices ranging from $774.05 to $774.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. |
Common Stock
|
8 |
| 2026-04-01 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 8 shares of Company stock on April 1, 2026 at prices ranging from $773.27 to $773.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. |
Common Stock
|
8 |
| 2026-04-01 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 4 shares of Company stock on April 1, 2026 at prices ranging from $778.02 to $778.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. |
Common Stock
|
4 |
| 2026-04-01 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 14 shares of Company stock on April 1, 2026 at prices ranging from $775.04 to $775.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. |
Common Stock
|
14 |
| 2026-04-01 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 40 shares of Company stock on April 1, 2026 at prices ranging from $779.65 to $779.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. |
Common Stock
|
40 |
| 2026-04-01 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 3 shares of Company stock on April 1, 2026 at prices ranging from $772.62 to $772.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. |
Common Stock
|
3 |
| 2026-03-02 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 10 shares of Company stock on March 2, 2026 at prices ranging from $783.25 to $783.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
Common Stock
|
10 |
| 2026-03-02 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 3 shares of Company stock on March 2, 2026 at prices ranging from $780.13 to $780.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
Common Stock
|
3 |
| 2026-03-02 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 2 shares of Company stock on March 2, 2026 at prices ranging from $787.02 to $787.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
Common Stock
|
2 |
| 2026-03-02 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 9 shares of Company stock on March 2, 2026 at prices ranging from $784.02 to $784.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
Common Stock
|
9 |
| 2026-03-02 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 2 shares of Company stock on March 2, 2026 at prices ranging from $781.00 to $781.42. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
Common Stock
|
2 |
| 2026-03-02 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 7 shares of Company stock on March 2, 2026 at prices ranging from $777.08 to $777.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
Common Stock
|
7 |
| 2026-03-02 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. |
Common Stock
|
20 |
| 2026-03-02 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 7 shares of Company stock on March 2, 2026 at prices ranging from $786.12 to $786.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
Common Stock
|
7 |
| 2026-03-02 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 2 shares of Company stock on March 2, 2026 at prices ranging from $778.27 to $778.33. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
Common Stock
|
2 |
| 2026-03-02 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 2 shares of Company stock on March 2, 2026 at prices ranging from $782.25 to $782.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
Common Stock
|
2 |
| 2026-03-02 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 11 shares of Company stock on March 2, 2026 at prices ranging from $785.02 to $785.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
Common Stock
|
11 |
| 2026-03-02 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 20 shares of Company stock on March 2, 2026 at prices ranging from $789.27 to $789.37. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
Common Stock
|
20 |
| 2026-03-02 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. Represents volume-weighted average price of sales of 5 shares of Company stock on March 2, 2026 at prices ranging from $779.36 to $779.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 2, 2026 at each separate price. |
Common Stock
|
5 |
| 2026-02-19 | Zoghbi Huda Y |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025. Represents volume-weighted average price of sales of 53 shares of Company stock on February 19, 2026 at prices ranging from $778.46 to $778.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. |
Common Stock
|
53 |
| 2026-02-19 | Zoghbi Huda Y |
Director |
Convert↓
Filing footnotes — Non-Qualified Stock Option (right to buy) (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025. The stock option vested in three equal annual installments, commencing one year after the date of grant. |
Non-Qualified Stock Option (right to buy)
|
1,638 |
| 2026-02-19 | Zoghbi Huda Y |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025. |
Common Stock
|
49 |
| 2026-02-19 | Zoghbi Huda Y |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025. |
Common Stock
|
1,638 |
| 2026-02-19 | Zoghbi Huda Y |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025. Represents volume-weighted average price of sales of 331 shares of Company stock on February 19, 2026 at prices ranging from $780.06 to $780.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. |
Common Stock
|
331 |
| 2026-02-19 | Zoghbi Huda Y |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025. |
Common Stock
|
4 |
| 2026-02-19 | Zoghbi Huda Y |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025. Represents volume-weighted average price of sales of 160 shares of Company stock on February 19, 2026 at prices ranging from $784.14 to $784.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. |
Common Stock
|
160 |
| 2026-02-19 | Zoghbi Huda Y |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025. Represents volume-weighted average price of sales of 298 shares of Company stock on February 19, 2026 at prices ranging from $782.01 to $782.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. |
Common Stock
|
298 |
| 2026-02-19 | Zoghbi Huda Y |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025. Represents volume-weighted average price of sales of 220 shares of Company stock on February 19, 2026 at prices ranging from $783.00 to $783.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. |
Common Stock
|
220 |
| 2026-02-19 | Zoghbi Huda Y |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025. Represents volume-weighted average price of sales of 56 shares of Company stock on February 19, 2026 at prices ranging from $785.60 to $785.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. |
Common Stock
|
56 |
| 2026-02-19 | Zoghbi Huda Y |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025. |
Common Stock
|
50 |
| 2026-02-19 | Zoghbi Huda Y |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025. Represents volume-weighted average price of sales of 208 shares of Company stock on February 19, 2026 at prices ranging from $779.10 to $779.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. |
Common Stock
|
208 |
| 2026-02-19 | Zoghbi Huda Y |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025. Represents volume-weighted average price of sales of 209 shares of Company stock on February 19, 2026 at prices ranging from $781.10 to $781.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price. |
Common Stock
|
209 |
| 2026-02-09 | RYAN ARTHUR F |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. |
Common Stock
|
1 |
| 2026-02-09 | Pitofsky Jason |
SVP Controller |
Sell↓
Filing footnotes — Common Stock (Direct)
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 10, 2025. Represents volume-weighted average price of sales of 521 shares of Company stock on February 9, 2026 at prices ranging from $776.05 to $776.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2026 at each separate price. |
Common Stock
|
521 |